Head-to-head · WeighScore
9amHealth vs eMI Aesthetics
The verdict
9amHealth takes it — 71.3/100 to 70.1/100, but only just.
9amHealth grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. 9amHealth (join9am.com) is a cardiometabolic telehealth platform offering whole-body care including weight management with FDA-approved branded GLP-1 medications such as Wegovy, Zepbound, and Saxenda, plus… eMI Aesthetics is close behind and may still be the better fit — see the factor split below.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | 9amHealth | eMI Aesthetics |
|---|---|---|
| WeighScore | 71.3/100 | 70.1/100 |
| Grade | C | C |
| Scorecard rank | #94 | #110 |
| Semaglutide | $149/mo (plus a separate fee, brand-name) | $179/mo (all doses, compounded) |
| Tirzepatide | Not disclosed | Not disclosed |
| Coverage | Coverage not published | All 50 states |
| Brand-name access | Yes | Yes |
| Oral / sublingual | Injection only | Yes |
Graded #94 · C
Strengths
- Prescribes FDA-approved branded GLP-1s (Wegovy, Zepbound, Saxenda)
- $149/month membership or free when covered by insurance
- Membership includes specialists, labs, devices, and medications
- Board-certified obesity specialists (DABOM), endocrinologists, dietitians, PharmDs
- Helps navigate insurance approvals; employer and state-plan partnerships
Where it loses points
- Medication coverage and GLP-1 access depend on insurance and BMI criteria
- State availability not enumerated on the public site
- Branded GLP-1s can be costly without insurance coverage
- Pricing for medications not transparently listed
Graded #110 · C
Strengths
- Available to eligible patients in all 50 states
- Offers both semaglutide and tirzepatide, plus an oral semaglutide option
- Intake and provider visits run through OpenLoop Health, an established telehealth network
Where it loses points
- Full per-drug pricing is not shown before intake; only an 'as low as 179/month' starting rate is published
- No fill pharmacy or named medical director is publicly listed
- Support appears limited to email, with no phone number or hours published
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.